For the past several years, physicians and compounding pharmacies have stepped in to address critical patient access gaps during U.S. Food and Drug Administration (FDA) shortage declarations for ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. Despite new rules limiting their manufacture, ...

Online advertising of glucagon-like peptide-1 (GLP-1) receptor agonists aimed at consumers who want to purchase compounded versions of the sought-after drugs are often misleading or inaccurate and ...

Compounded tirzepatide contains the same active ingredient as Mounjaro but may differ in quality, ingredients, and dosage. The Food and Drug Administration (FDA) does not regulate its safety, ...